FSD Pharma Inc. | WebDisclosure

Basculer en Français

10925	Companies
238406	Keywords
167218	Articles
128082	Press releases

Home
Companies
FSD Pharma Inc.

PRESS RELEASE

published on 05/31/2024 at 13:30, 2 years 3 months ago

FSD Pharma, Inc. Wins Petition to Confirm Arbitration Awards Entered Against Dr. Raza Bokhari Totaling Over $3 Million CAD, Plus Interest
FSD Pharma Inc. confirms arbitration awards against former CEO Dr. Raza Bokhari. United States District Court grants final judgment for monetary damages. Company focuses on biopharmaceutical solutions for neurodegenerative disorders

FSD Pharma Inc. Arbitration Awards Neurodegenerative Disorders United States District Court Biopharmaceutical Solutions
BRIEF

published on 05/28/2024 at 14:05, 2 years 3 months ago

FSD Pharma soumet un protocole d'essai clinique pour Unbuzzd™ dans le traitement de l'intoxication alcoolique aiguë

FSD Pharma Essai Clinique Unbuzzd™ Intoxication Alcoolique Essai METAL-2
BRIEF

published on 05/28/2024 at 14:05, 2 years 3 months ago

FSD Pharma Submits Clinical Trial Protocol for Unbuzzd™ in Acute Alcohol Intoxication

FSD Pharma Clinical Trial Unbuzzd™ Alcohol Intoxication METAL-2 Trial
PRESS RELEASE

published on 05/28/2024 at 14:00, 2 years 3 months ago

FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
FSD Pharma submits clinical trial protocol for Unbuzzd(TM) to assess safety and efficacy in a crossover design trial to study effects on alcohol intoxication. Dr. Andrzej Chruscinski comments on the milestone reached

FSD Pharma Unbuzzd(TM) Alcohol Intoxication Clinical Trial Protocol Dr. Andrzej Chruscinski
BRIEF

published on 05/24/2024 at 20:39, 2 years 3 months ago

FSD Pharma annonce un accord de relations avec les investisseurs avec IR Agency LLC

Biopharmaceutique FSD Pharma Relations Avec Les Investisseurs Agence RI Psychéeutiques Lucides
BRIEF

published on 05/24/2024 at 20:39, 2 years 3 months ago

FSD Pharma Announces Investor Relations Agreement with IR Agency LLC

Investor Relations FSD Pharma Biopharmaceutical IR Agency Lucid Psycheceuticals
PRESS RELEASE

published on 05/24/2024 at 20:34, 2 years 3 months ago

FSD Pharma Provides Corporate Update
FSD Pharma Inc. enters investor relations services agreement with IR Agency LLC, focusing on communicating information to the financial community. Company building innovative biotech solutions

Investor Relations FSD Pharma Inc. Biopharmaceutical Innovative Assets IR Agency LLC
BRIEF

published on 05/16/2024 at 14:05, 2 years 3 months ago

FSD Pharma Announces New Packaging for Unbuzzd™ Beverage

FSD Pharma Beverage Industry Unbuzzd New Packaging Responsible Drinking
BRIEF

published on 05/16/2024 at 14:05, 2 years 3 months ago

FSD Pharma annonce un nouvel emballage pour la boisson Unbuzzd™

FSD Pharma L'industrie Des Boissons Consommation Responsable Unbuzzd Nouvel Emballage
PRESS RELEASE

published on 05/16/2024 at 14:00, 2 years 3 months ago

FSD Pharma Provides Update on Celly Nu's New Packaging for unbuzzd(TM)
FSD Pharma Inc. announces new packaging and logo for unbuzzd™ beverage product in collaboration with Celly Nutrition Corp. and Six+One, set to launch this summer, targeting alcohol metabolizing and promoting alertness

FSD Pharma Inc. Celly Nutrition Corp. Unbuzzd Six+One Packaging Logo

Accesswire

Published on 09/02/2026 at 22:55, 12 hours 52 minutes ago

Secure Blockchain Sells Delivery Trust(R) Business
Published on 09/02/2026 at 18:45, 17 hours 2 minutes ago

Full Circle Lithium Rebrands as FCL-X Fire & Safety Inc. and Provides Corporate Update
Published on 09/02/2026 at 15:00, 20 hours 47 minutes ago

Vox Royalty Enters into Binding Agreement to Acquire the White Dam Gold Royalty in Australia
Published on 09/02/2026 at 14:30, 21 hours 17 minutes ago

Solitario Completes Phase-One Drilling at Golden Crest - Reports Initial Drill Results for Ponderosa
Published on 09/02/2026 at 14:00, 21 hours 47 minutes ago

Orogen Royalties Acquires Two Gold Projects in Southwest Utah

View all ACCESSWIRE

EQS Group

Published on 09/03/2026 at 11:30, 17 minutes ago

u-blox enhances GNSS timing validation with nanosecond-accurate METAS time service
Published on 09/03/2026 at 11:30, 17 minutes ago

Four Years of Partnership, Striving for Excellence | XTrend Speed × AFA Renew Sponsorship for the Fourth Consecutive Year
Published on 09/03/2026 at 11:00, 47 minutes ago

ABB Ltd: ABB share buybacks - August 27, 2026 - September 2, 2026
Published on 09/03/2026 at 10:30, 1 hour 17 minutes ago

EcoGraf Limited: Underwritten Share Purchase Plan
Published on 09/03/2026 at 10:29, 1 hour 18 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungs AG (von East Value Research GmbH ):

Les Echos

Published on 09/03/2026 at 09:00, 2 hours 47 minutes ago

Transfert effectif des titres Gerard Perrier Industrie sur Euronext Growth Paris à compter du 7 septembre 2026
Published on 09/03/2026 at 07:00, 4 hours 47 minutes ago

Excellent portfolio performance leads to a 7.5% increase in Net Asset Value to EUR 57.2 per share
Published on 09/03/2026 at 07:00, 4 hours 47 minutes ago

Excellent portfolio performance leads to a 7.5% increase in Net Asset Value to EUR 57.2 per share
Published on 09/03/2026 at 07:00, 4 hours 47 minutes ago

Uitstekende portefeuilleprestaties leiden tot stijging van de intrinsieke waarde met 7,5% tot EUR 57,2 per aandeel
Published on 09/02/2026 at 21:30, 14 hours 17 minutes ago

Accor announces the success of OCEANEs due 2032 for a nominal amount of €380 million and the results of the partial repurchase of its outstanding OCEANEs due 2027

View all LES ECHOS COMFI WIRE